Abstract
Background: Interleukin-35 is a novel inhibitory cytokine. Results: Interleukin-35 inhibits vascular endothelial cell activation by suppressing MAPK-AP1-mediated VACM-1 expression in LPS-induced acute inflammation. Conclusion: Interleukin-35 suppresses acute vascular endothelium response. Significance: Interleukin-35 may be an attractive reagent for anti-inflammatory therapy.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 19307-19318 |
| Number of pages | 12 |
| Journal | Journal of Biological Chemistry |
| Volume | 290 |
| Issue number | 31 |
| DOIs | |
| State | Published - Jul 31 2015 |
ASJC Scopus subject areas
- Biochemistry
- Molecular Biology
- Cell Biology
Fingerprint
Dive into the research topics of 'Interleukin-35 inhibits endothelial cell activation by suppressing MAPK-AP-1 Pathway'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS